# DIBBS #SPE2DP-27-T-0282

DLA request for a package of premixed lidocaine and dextrose injection

**Posted:** November 12, 2026
**Respond By:** November 17, 2026
**Identifier:** SPE2DP-27-T-0282
**NAICS:** 424210, 325412

DLA Troop Support is seeking one package of premixed lidocaine hydrochloride and dextrose injection for its Medical Supply Chain Pharmaceutical FSA.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contact: Meghan Smink.
- **Product and quantity:** 1 package of lidocaine hydrochloride and dextrose injection, 500 mL bags, 18 units per package (18 EA).
- **Identifiers:** NSN 6505-01-194-7265; **Baxter Healthcare Corp IV** part number 2B0973P; NDC 00338-0409-03.
- **OEMs named:** **Baxter Healthcare Corp IV** is the listed manufacturer. Hospira is also mentioned in connection with supply shortages.
- **Notable requirements:** At least 16 months of the product's 18-month shelf life must remain when delivered. Delivery is required within 20 days after award. The notice describes limited supply availability and manufacturing delays affecting premixed lidocaine injections.

### Description

LIDOCAINE HYDROCHLO (QTY: 1, NSN: 6505-01-194-7265, Purchase Request: 7013324492)
  Approved Sources:
  - CAGE: 04687, Part No: 2B0973P
  - CAGE: 04687, Part No: NDC00338-0409-03
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0282)